StockData
LKFTNasdaqPharmaceutical PreparationsAlso trades as GLPGF

Lakefront Biotherapeutics NV

Financials through fiscal 2025, year ended Dec 31, 2025Last filing: 20-F on Mar 26, 2026
$29.79−0.11 (-0.37%)

Close on Oct 19, 2026

Lakefront Biotherapeutics NV revenue by segment

No segment breakdown reported

Lakefront Biotherapeutics does not break out revenue by segment, region or product in the tagged data of its filings for this period type.